Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot

The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users

Recruiting

Interested in participating?

Key information

Conditions

Hepatitis B AIDS Acquired Immunodeficiency Syndrome Blood-Borne Infections Communicable Diseases DNA Virus Infections Digestive System Diseases Flaviviridae Infections Genital Diseases HIV Infections Hepadnaviridae Infections Hepatitis Hepatitis C Hepatitis, Viral, Human Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections Liver Diseases RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Slow Virus Diseases Urogenital Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Caarud Sud Manche, Avranches, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Former or active intravenous and/or nasal drug user
Person on opiate substitution therapy

Exclusion criteria

Person with known active viral infection(s)

Treatment and study plan

Blood collection using Dried Blood Spot

Diagnostic Test

Drug users will be screened for Hepatitis C, Hepatitis B and AIDS using Dried Blood Spot for blood collection

Primary outcomes

Number of person with an active hepatitis C infection

Time frame: Day 1
Number of person with an active hepatitis B infection

Time frame: Day 1
Number of person with an active AIDS infection

Time frame: Day 1

Study contacts

Contact information is provided by the study sponsor or research team.

Ghassan RIACHI, MD

CONTACT

[email protected]

+3323288 ext. 8265

Julien BLOT

CONTACT

[email protected]

+3323288 ext. 8265

Sponsors and collaborators

Lead sponsor

University Hospital, Rouen

Other

Registry information

Acronym: BUVARD76_27

Important dates

Study start: 2022
Primary completion: 2027
Study completion: 2027
First posted: May 25, 2022
Registry last updated: Feb 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Enrolling by Invitation